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Abstract 
Consumption of plant sterol esters reduces plasma LDL cholesterol concentration by inhibiting in-
testinal cholesterol absorption. Commercially available plant sterol esters are prepared by esterifying 
free sterols to fatty acids from edible plant oils such as canola, soybean, and sunflower. To determine 
the influence of the fatty acid moiety on cholesterol metabolism, plant sterol esters were made with 
fatty acids from soybean oil (SO), beef tallow (BT), or purified stearic acid (SA) and fed to male ham-
sters for 4 wk. A control group fed no plant sterol esters was also included. Hamsters fed BT and SA 
had significantly lower cholesterol absorption and decreased concentrations of plasma non-HDL 
cholesterol and liver esterified cholesterol, and significantly greater fecal sterol excretion than SO 
and control hamsters. Cholesterol absorption was lowest in hamsters fed SA (7.5%), whereas it was 
72.9% in control hamsters. Cholesterol absorption was correlated with fecal sterol excretion (r = –0.72, 
P < 0.001), liver cholesterol concentration (r = 0.88, P < 0.001), and plasma non-HDL cholesterol con-
centration (r = 0.85, P < 0.001). A multiple regression model that included each sterol ester type vs. 
cholesterol absorption indicated that intake of steryl stearate was the only dietary component that 
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contributed significantly to the model (R2 = –0.75, P < 0.001). Therefore, our results demonstrate that 
BT and SA are more effective than SO in reducing cholesterol absorption, liver cholesterol, and plasma 
non-HDL cholesterol concentration, suggesting that cardioprotective benefits can be achieved by 
consuming stearate-enriched plant sterol esters. 
 
Abbreviations: BT, diets containing plant sterols esterified to fatty acids from beef tallow; SA, diets 
containing plant sterols esterified to purified stearic acid; SO, diets containing plant sterols esterified 
to fatty acids from soybean oil. 
 
Introduction 
 
The direct association between plasma LDL cholesterol concentration and risk for coronary 
heart disease is well established (1). The most recent guidelines of the National Cholesterol 
Education Program indicate an LDL cholesterol goal of < 2.6 mmol/L (100 mg/dL) for high-
risk individuals and < 1.8 mmol/L (70 mg/dL) for very high-risk individuals (2). However, 
the mean LDL cholesterol level of U.S. adults exceeds 3.1 mmol/L (3), so achieving the 
target LDL goals generally requires therapeutic intervention. Statin drugs provide effec-
tive cholesterol-lowering therapy and are widely prescribed, but they can cause severe ad-
verse effects (4). Lowering plasma LDL cholesterol through nondrug strategies, such as 
consuming specific food components, would therefore be most desirable. 
Consumption of foods enriched with plant sterols (or stanols) in free or esterified form 
can significantly lower plasma LDL cholesterol concentration. At least 40 clinical studies 
have been conducted in recent years that indicate a daily dose of 1–3 g of plant sterols 
significantly reduces plasma LDL cholesterol concentration 10–15% (5,6). It appears that a 
dose-response relation is continuous up to ~2 g/d (5,7). As a secondary therapy, adding 
plant sterols to statin medication is more effective than doubling the statin dose (5). Ac-
cordingly, the National Cholesterol Education Program recommends 2 g/d of plant sterol 
or stanol esters as a therapeutic option for reducing plasma LDL cholesterol concentration 
(8). 
The primary cholesterol-lowering mechanism of plant sterols is their ability to reduce 
intestinal cholesterol absorption (9). Inverse correlations between plant sterol intake and 
cholesterol absorption have been reported in rabbits (10), hamsters (10,11), and humans 
(12), and positive correlations between cholesterol absorption and plasma LDL cholesterol 
concentration have been found in humans (13,14). Consumption of plant sterols also pro-
motes fecal cholesterol excretion in rats (15), hamsters (11), and humans (16,17). 
Plant sterols are often esterified to improve their functionality and incorporation into 
food products. In the 1970s, Mattson and colleagues (18–20) discovered that esterifying 
plant sterols with long-chain fatty acids increased their solubility in oil 10-fold and that 
esterification did not impair their ability to inhibit cholesterol absorption. Commercial 
preparations of plant sterol esters utilize common vegetable oils (e.g., canola, soybean, and 
sunflower) as the fatty acid source. The extent to which the fatty acid moiety of plant sterol 
esters influences cholesterol absorption is not known. In this study, plant sterol esters were 
prepared with variable amounts of saturated and unsaturated fatty acids to test their ef-
fects on cholesterol absorption, sterol balance, and plasma cholesterol concentration. 
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Materials and Methods 
 
Plant sterol ester preparation 
Unesterified (free) sterols from soybeans were obtained from Archer Daniels Midland and 
were composed of ~48% sitosterol, 27% campesterol, and 21% stigmasterol as determined 
by gas chromatography using a DB-5 capillary column. The free sterols were esterified 
with fatty acids from refined soybean oil, beef tallow, or purified stearic acid. 
Prior to esterification, free fatty acids were prepared from the edible oil triglycerides. 
Approximately 100 g of oil/fat was added to 360 mL of a 2.5-mol/L KOH solution in ethanol: 
water (1:1, v:v). The mixture was heated in a boiling water bath for 30 min, then added to 
3500 mL of a 3.4-mol/L NaCl solution while stirring. The mixture was poured through a 
Buchner funnel and washed with ~500 mL of ice-cold deionized water to remove excess 
KOH and glycerol. The fatty acid salts were spread onto a clean plastic tray and dried in a 
vacuum oven at 50°C. After dissolving fatty acid salts in 4000 mL deionized water, a molar 
excess of 6 mol/L HCl was added and stirred for 30 min, forming insoluble fatty acids. The 
mixture was poured through a Buchner funnel and washed with ~500 mL deionized water 
to remove excess HCl and KCl. Fatty acids were transferred to a plastic tray and dried in a 
vacuum oven at 50°C. 
The esterification procedure was a modification of a method by Kuksis and Beveridge 
(21). Free fatty acids were first converted to the acid chlorides by reacting with oxalyl chlo-
ride in benzene with dimethyl formamide as a catalyst. The mixture was then concentrated 
by evaporation under vacuum. Unesterified plant sterols were dissolved in a clean flask 
containing ethanol-free chloroform and 2 molar equivalents of pyridine. A solution con-
taining a slight molar excess of the fatty acid chloride in ethanol-free chloroform was 
added dropwise and the mixture was stirred overnight to maximize the esterification re-
action. The reaction mixture was diluted with water and the aqueous layer was acidified 
with HCl to pH 3–4. The separated chloroform layer was dried over sodium sulfate and 
concentrated under vacuum. The resulting solid was redissolved in hot ethanol; cooling 
the solution resulted in selective recrystallization of the plant sterol esters. The esters were 
collected by vacuum filtration, washed with excess cold ethanol, and analyzed for purity 
by thin-layer chromatography using a solvent system of hexane:diethyl ether:acetic acid 
(70:30:1, by vol). Plant sterol esters represented > 90% of the product in each preparation, 
with the remainder consisting mainly of unesterified free sterol. 
Water activity, moisture, solubility, specific gravity, and fatty acid distribution were de-
termined for each plant sterol ester preparation (Table 1). Water activity was assessed at 
24°C using an Aqualab system (Decagon Devices) and was based on a standard of 6.0 mol/L 
NaCl in water. Moisture was determined by drying samples overnight at 130°C. The solu-
bility and specific gravity were measured in 4 different oils: canola, olive, soybean, and 
sunflower. Solubility was determined by adding the esters in small increments and observ-
ing the concentration at which a cloudy appearance was maintained when stirred for sev-
eral hours at room temperature. Specific gravity was performed using a pycnometer at 
room temperature. Fatty acid composition was determined by gas chromatography of fatty 
acid methyl esters (22). 
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Table 1. Characteristics of plant sterol esters1 
 SO BT SA 
Water activity 0.60 0.63 0.58 
Moisture, g/100 g < 1 < 1 < 1 
Solubility in oil, g/100 g 5.73 1.26 0.89 
Specific gravity 0.98 0.98 0.98 
Fatty acid profile, g/100 g total fatty acids    
     Palmitic acid 11.7 37.5 3.2 
     Stearic acid 3.4 18.6 96.8 
     Oleic acid 22.8 28.8 nd2 
     Linoleic acid 59.6 2.1 nd 
1. Soybean sterols esterified with fatty acids from SO, BT, or SA. 
2. Not detected. 
 
Animals and diets 
Thirty-five male F1B Syrian hamsters (BioBreeders) weighing ~90–100 g were housed indi-
vidually in polycarbonate cages with sawdust bedding. Upon arrival, the hamsters were 
randomly divided into groups of 8–9 hamsters and given free access to food and water 
throughout the 4-wk study. Hamsters were kept in a humidity-controlled room at 25°C, 
using a 12-h light/dark cycle for the duration of the study. All procedures were approved 
by the Institutional Animal Care and Use Committee of the University of Nebraska. 
Hamsters were fed a control diet (devoid of plant sterol esters) or diets containing 50 g/kg 
plant sterol esters esterified with fatty acids from soybean oil (SO), beef tallow (BT), or purified 
stearic acid (SA) (Table 2). The AIN-93 mineral and vitamin mixes and beef tallow were 
purchased from Dyets. The dietary protein source was 90% lean ground beef purchased at 
a local grocery store and freeze-dried at the Food Processing Center at the University of 
Nebraska. The freeze-dried beef was pulverized and sifted to provide a homogenous pow-
der. After the ground beef was freeze-dried, its composition of protein, fat, and ash was 
64, 32, and 3 g/100 g, respectively. Ground beef was added to the diets at 500 g/kg, thus 
contributing 160 g fat/kg diet. The fatty acid moiety of plant sterol esters contributed an 
additional 20 g fat/kg diet; the control diet contained 20 g/kg of BT to mimic the amount of 
additional fat contributed by the plant sterol esters. Fiber was added to the control diet at 
30 g/kg to substitute for the sterol moiety contributed by plant sterol esters. Therefore, all 
diets contained 180 g fat/kg. The energy distribution for fat, carbohydrate, and protein in 
each diet was 36, 35, and 29%, respectively. All ingredients were combined and mechani-
cally mixed; the BT was first melted at low temperature before adding to the control diet. 
Diets were stored at –20°C. 
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Table 2. Composition of hamster diets containing plant sterols esterified with fatty acids from 
SO, BT, or purified SA 
 Control SO BT SA 
 g/kg 
Ground beef1 500 500 500 500 
Cornstarch 305 305 305 305 
Sucrose 50 50 50 50 
Plant sterol esters — 50 50 50 
     Steryl palmitate — 5.8 18.8 1.6 
     Steryl stearate — 1.7 9.3 48.4 
     Steryl oleate — 11.4 14.4 0.0 
     Steryl linoleate — 29.8 1.1 0.0 
Fiber2 80 50 50 50 
BT3 20 — — — 
AIN-93 mineral mix4 35 35 35 35 
AIN-93 vitamin mix4 10 10 10 10 
1. 90% lean, freeze-dried. 
2. Solka-Floc 200. 
3. Fatty acid composition (g/100 g): palmitic, 25; stearic, 19; oleic, 42; linoleic, 3. 
4. Reeves et al. (23). 
 
Experimental procedures 
Body wt and food intake were recorded weekly during the 4-wk study. Cholesterol ab-
sorption efficiency was determined during wk 3, and feces were collected during wk 4 to 
quantify fecal neutral steroid and bile acid excretion. Food was removed on d 28 and the 
hamsters were killed on d 29 by CO2 asphyxiation. The abdomen and thorax were opened 
by incision, and blood was collected by cardiac puncture. Plasma was obtained by centri-
fuging at 4°C at 2000 × g; 30 min. The liver was perfused with saline via the hepatic portal 
vein to remove residual blood, and the liver and small intestine were excised, weighed, 
and immediately frozen in liquid N2. 
Cholesterol absorption and fecal neutral steroids were measured as previously described 
(24). Fecal bile acids were measured enzymatically (Wako Chemicals) following extraction 
and solubilization in Triton X-100 (25). Liver lipids were determined as previously de-
scribed (25) using enzymatic reagents for total cholesterol (Roche Diagnostics,), triglycer-
ides (Roche), free cholesterol (Wako), and phospholipids (Wako). Liver esterified cholesterol 
was calculated as the difference between total and free cholesterol. Plasma total cholesterol 
was measured enzymatically (Roche); HDL cholesterol was quantified after precipitating 
apoB-containing lipoproteins (Precipitating Reagent 1335–250; Thermo Electron). 
 
Statistical analyses 
Summarized data are expressed as means ± SEM. Treatment differences were determined 
by ANOVA, followed by Tukey’s multiple comparison procedure. Differences were consid-
ered significant at the P < 0.05 level. Data for liver esterified cholesterol were log-transformed 
prior to statistical analysis. Associations between 2 variables (e.g., liver weight vs. esteri-
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fied cholesterol concentration) were assessed using simple linear regression analysis. As-
sociations between multiple variables (e.g., intake of each plant sterol ester type vs. cho-
lesterol absorption) were assessed by stepwise multiple regression. All data were analyzed 
using SigmaStat 3.0 (SPSS). 
 
Results 
 
Body wt of all hamsters was 93.9 ± 1.2 g at the beginning of the study and increased to 
118.2 ± 1.8 g on d 29. Body wt gain and food intake during the 4-wk study did not differ 
among treatment groups. 
Hamsters fed BT and SA diets had plasma non-HDL cholesterol concentrations that 
were 64 and 73% lower, respectively, than the control group (Table 3). Plasma HDL cho-
lesterol concentration also was reduced in hamsters fed plant sterol esters, although the 
magnitude of change was much less than the changes in non-HDL cholesterol. Significant 
reductions in liver free cholesterol occurred in the BT and SA groups, whereas all hamsters 
fed plant sterol esters had significantly lower liver esterified cholesterol concentrations 
than control hamsters. Hamsters fed the BT and SA diets had 96 and 99% reductions in 
liver esterified cholesterol, respectively. Relative liver weights also were less than in con-
trol groups in hamsters fed plant sterol esters (Table 3). Liver weight was directly corre-
lated with liver esterified cholesterol concentration (r = 0.82, P < 0.001) when all data were 
plotted, suggesting that changes in liver weight were mainly due to the esterified choles-
terol content. Liver triglyceride concentration was highly variable among hamsters and no 
significant treatment effects were found. 
 
Table 3. Plasma cholesterol, liver weight, and liver lipid concentration in hamsters fed diets 
containing soybean sterols esterified with fatty acids from SO, BT, or purified SA1 
 Control SO BT SA 
Plasma non-HDL cholesterol, mmol/L 2.91 ± 0.21b 2.78 ± 0.24b 1.03 ± 0.06a 0.79 ± 0.07a 
Plasma HDL cholesterol, mmol/L 1.77 ± 0.05c 1.28 ± 0.03b 1.23 ± 0.04ab 1.09 ± 0.05a 
Liver weight, g/100 g body wt 3.58 ± 0.08d 3.34 ± 0.05c 2.86 ± 0.06b 2.51 ± 0.07a 
Liver free cholesterol, μmol/g 5.21 ± 0.42b 5.10 ± 0.43b 4.12 ± 0.60a 4.27 ± 0.33a 
Liver esterified cholesterol, μmol/g 26.04 ± 5.24c 13.63 ± 3.13b 1.10 ± 0.77a 0.21 ± 0.28a 
Liver triglyceride, μmol/g 6.00 ± 2.03 9.99 ± 5.92 7.44 ± 3.18 9.09 ± 4.85 
1. Values are means ± SEM, n = 9, except for control, n = 8. Means in a row without a common letter differ, 
P < 0.05. 
 
Cholesterol absorption was significantly reduced in each group fed plant sterol esters 
compared with control hamsters, with the SA group having the lowest absorption at 7.5% 
(Table 4). Fecal neutral sterol excretion was significantly greater in all groups fed plant 
sterol esters compared with control groups, with intake of BT and SA resulting in a greater 
rate than SO. Fecal bile acid excretion was significantly lower in the BT and SA groups 
compared with control hamsters, although bile acid excretion represented < 9% of total 
sterol excretion in the BT and SA groups. Fecal total sterol excretion was therefore signifi-
cantly greater in all groups fed plant sterol esters than in control hamsters (data not shown). 
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In addition, cholesterol absorption was correlated with fecal sterol excretion (r = –0.72, 
P < 0.001), liver cholesterol concentration (r = 0.88, P < 0.001), and plasma non-HDL choles-
terol concentration (r = 0.85, P < 0.001). 
 
Table 4. Cholesterol absorption and fecal sterol excretion in hamsters fed diets containing soybean 
sterols esterified with fatty acids from SO, BT, or purified SA1 
 Control SO BT SA 
Cholesterol absorption, % 72.9 ± 1.8d 56.4 ± 2.4c 29.8 ± 2.5b 7.5 ± 1.9a 
Fecal neutral sterol excretion, 
     μmol/(d × 100 g body wt) 
3.15 ± 0.41a 5.82 ± 0.48b 8.17 ± 0.52c 8.12 ± 0.56c 
Fecal bile acid excretion, 
     μmol/(d × 100 g body wt) 
1.48 ± 0.17b 1.17 ± 0.18ab 0.77 ± 0.06a 0.65 ± 0.12a 
1. Values are means ± SEM, n = 9, except for control, n = 8. Means in a row without a common letter differ, 
P < 0.05. 
 
Because differences in cholesterol absorption were due to differences in fatty acid com-
position of plant sterol esters, we compared cholesterol absorption with the intake of plant 
steryl palmitate, stearate, oleate, and linoleate (calculated from dietary plant sterol ester 
composition in Table 2 and total daily food intake for each hamster). A multiple regression 
model that included each sterol ester type vs. cholesterol absorption indicated that intake 
of steryl stearate was the only dietary component that contributed significantly to the 
model (R2 = –0.75, P < 0.001). The intake of steryl stearate in hamsters fed the SO, BT, and 
SA diets was 16.5 ± 0.3, 89.7 ± 1.6, and 424.7 ± 8.9 μmol/d, respectively. Fecal sterol excre-
tion, liver cholesterol, and plasma non-HDL cholesterol are plotted as a function of plant 
steryl stearate intake in Figure 1. 
 
Discussion 
 
Consumption of plant sterol esters reduces plasma LDL cholesterol concentration by in-
hibiting intestinal cholesterol absorption (9). Commercially available plant sterol esters are 
prepared by esterifying free sterols to fatty acids from edible plant oils such as canola, 
soybean, and sunflower. To determine the influence of the fatty acid moiety on cholesterol 
metabolism, plant sterol esters were made with fatty acids from SO, BT, or purified SA and 
fed to male hamsters. The goal was to provide plant sterol esters with markedly different 
fatty acid compositions (Table 2) while keeping the sterol moiety constant. Our results 
demonstrate that plant sterol esters enriched with stearic acid (i.e., the BT and SA diets) 
were significantly more effective than SO in reducing cholesterol absorption, liver choles-
terol, and plasma non-HDL cholesterol concentration. 
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Figure 1. Plant steryl stearate intake and fecal sterol excretion (A), liver cholesterol con-
centration (B), and non-HDL cholesterol concentration (C) in hamsters fed diets contain-
ing soybean sterols esterified with fatty acids from SO, BT, or purified SA. Each point 
represents the means ± SEM, n = 9, except for control, n = 8. 
 
The contribution of the fatty acid moiety to the cholesterol-lowering ability of plant 
sterol esters has been largely overlooked in previous research. Virtually all studies to date 
have examined plant sterols esterified to fatty acids from common plant oils, as is current 
practice in the food industry. Three recent animal studies have investigated the metabolic 
impact of plant sterols esterified to fish oil fatty acids. Male guinea pigs fed plant sterol–
fish oil esters had a significantly lower non-HDL cholesterol concentration compared with 
control groups fed no plant sterols or fish oil (26). Insulin-resistant rats fed plant sterol–
fish oil esters had significantly lower serum triglyceride and total cholesterol compared 
R A S M U S S E N  E T  A L . ,  J O U R N A L  O F  N U T R I T I O N  1 3 6  (2 0 0 6 )  
9 
with rats fed no plant sterols or fish oil (27). Unfortunately, the rat and guinea pig studies 
lacked either a plant sterol or fish oil control (26,27), so it was not possible to determine 
whether the results were due to plant sterols per se, fish oil fatty acids per se, or a combined 
effect of the plant sterol–fish oil esters. Demonty et al. (28) reported that male hamsters fed 
plant sterol–fish oil esters had a significantly lower non-HDL cholesterol concentration 
than hamsters fed unesterified plant sterols. Although the results of the hamster study 
point to fish oil fatty acids as a contributing factor, no other sterol ester preparations were 
tested, nor did the unesterified plant sterol diet include an equivalent amount of fish oil 
(28), so the contribution of the fatty acids as part of the sterol ester molecule could not be 
assessed. A recent human study tested the following dietary preparations: plant sterols 
esterified to fish oil fatty acids, plant sterols esterified to sunflower oil fatty acids, unester-
ified sterols plus fish oil, unesterified sterols only, and a control diet without sterols or fish 
oil (29). The plasma LDL cholesterol concentration did not significantly differ among the 
treatment groups, suggesting that the fatty acid content (delivered in esterified or unester-
ified form) did not contribute to the regulation of LDL cholesterol (29). To our knowledge, 
this is the only published study (29) that directly compares plant sterol ester preparations 
differing in their fatty acid composition. 
Plant sterol esters containing stearic acid were the most potent cholesterol-lowering 
sterol esters in this study. The cholesterol-lowering or neutral properties of stearic acid, 
independent of plant sterol intake, are widely recognized, even though the mechanisms of 
action have not been fully characterized. Stearic acid is a long-chain saturated fatty acid, 
but it does not raise LDL cholesterol, in contrast to other saturated fatty acids (30). Studies 
in rats (31–34) and hamsters (24) have shown that stearic acid reduces cholesterol absorp-
tion. Dietary stearic acid also reduces liver cholesterol concentration (35,36) and promotes 
fecal sterol excretion (24,37,38) compared with other saturated fatty acids. Similarly, con-
sumption of plant sterols, independent of dietary fatty acids, produces the same metabolic 
responses in humans (16,39), rats (15,19), and hamsters (11,40). This study’s results (Fig. 1) 
indicate that reductions in plasma and liver cholesterol, as well as increased fecal sterol 
excretion, were achieved with relatively modest intakes of steryl stearate (BT diet), sug-
gesting that cardioprotective benefits can be achieved by consuming stearate-enriched 
plant sterol esters. Because plant sterol esters may be hydrolyzed to some extent in the 
small intestine (41), the cholesterol-lowering properties observed in this study may be the 
result of multiple mechanisms involving free stearic acid and free plant sterols. We recently 
reported that intestinal FHs 74 Int cells incubated with stearic acid, compared with palmitic 
acid, had significantly reduced gene expression of the cholesterol transporter Niemann-
Pick C1 Like 1, suggesting intracellular regulation of cholesterol absorption by stearic acid 
(42). In a separate study, we reported that plant sterols have the ability to displace choles-
terol from micelles in vitro (43), suggesting an intralumenal mechanism that would likely 
decrease cholesterol solubility in vivo and its ability to be absorbed. The extent to which 
plant sterols and stearic acid act through independent or synergistic mechanisms will re-
quire further study. 
Clinical studies have repeatedly shown that plant sterol intakes of 1–3 g/d significantly 
reduce plasma LDL cholesterol concentration up to 15% and that higher intakes have little 
added influence (5,6). The majority of human studies included plant sterol esters made 
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with fatty acids from plant oils. In the current study, hamsters fed the SO diet showed a 
5% decrease (P > 0.05) in plasma non-HDL cholesterol concentration, which is within the 
scope of previous human studies. In contrast, hamsters fed BT and SA showed reductions 
in non-HDL cholesterol of 64 and 73%, respectively. These impressive reductions are much 
greater than previously reported in humans consuming plant sterols esterified to plant oil 
fatty acids. It could be argued that plasma cholesterol response to dietary factors is differ-
ent in hamsters compared with humans, although the modest change observed in the SO 
group is consistent with humans and does not support the argument. Other studies have 
noted the similarities in cholesterol metabolism between hamsters and humans (44–47), 
thus supporting the use of hamsters in modeling the human response to dietary treatment. 
Nevertheless, a human study that directly tests stearate-enriched plant sterol esters would 
be helpful in this regard. 
In conclusion, BT and SA were significantly more effective than SO in reducing choles-
terol absorption, liver cholesterol, and plasma non-HDL cholesterol concentration. The pri-
mary cholesterol-lowering feature of BT and SA was enrichment of plant sterol esters with 
stearic acid. Our findings reinforce the clinical importance of plant sterol esters in the man-
agement of hypercholesterolemia, while demonstrating the involvement of the fatty acid 
moiety. The consumption of stearate-enriched plant sterol esters appears to provide supe-
rior benefits to cardiovascular health. 
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